The information contained within this announcement is deemed by the Company to constitute inside information as stipulated by the Market Abuse Regulation (EU) No.596/2014, as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"). Upon the publication of this announcement, the inside information is now considered to be in the public domain. July 27, 2023 Strong H1 and Q2 2023 Financial Results; FY 2023 Guidance Raised • Q2 2023 SUBLOCADE® Net Revenue (NR) of $155m, +58% versus ...

Thank you for taking my questions. Three, please. The first one on litigation. The press release mentioned that new offers and demands have been exchanged with the state in the context of the MDL litigation. So just curious to know why the states have been singled out here? What about the other classes of [indiscernible] purchasers and payers, which are also involved in the MDL? Is there any reason why they have been excluded from these additional exchanges? So that's the first question. Second one, on the ...

Important cautionary statement regarding forward-looking statements This presentation contains certain statements that are forward-looking. Forward-looking statements include, among other things, statements regarding the Indivior Group's financial guidance for 2023 and its medium- and long-term growth outlook; strategies for value creation; expectations for sales levels for particular products; expectations regarding the cost to resolve the Group's legal proceedings and regulatory matters; the timing of our ...

Conference Call Participants I would now like to hand the conference over to your host today, Jason Thompson. Please go ahead. Mark Crossley Touching briefly on our fiscal year 2023 guidance, we expect to deliver another year of attractive profitable growth. Ryan will take you through the details in a few minutes but I would highlight that we do plan to deliver top line growth and positive operating leverage in 2023, consistent with the medium-term financial outlook we We have participated in very early-sta ...

Indivior PLC (INVVY) Q3 2022 Earnings Conference Call October 27, 2022 8:00 AM ET Company Participants Mark Crossley - CEO Ryan Preblick - CFO Conference Call Participants Thibault Boutherin - Morgan Stanley James Vane-Tempest - Jefferies Max Herrmann - Stifel Paul Cuddon - Numis Operator Good day, and thank you for standing by. Welcome to IndiviorÂ's Q3 Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there'll be a question-and-answer sess ...

Indivior PLC Q3 2022 Results October 27, 2022 Mark Crossley Chief Executive Officer Forward-looking statements This presentation contains certain statements that are forward-looking. Forward-looking statements include, among other things, statements regarding the Indivior Group's financial guidance for 2022 and its medium- and long-term growth outlook; expectations for profitable growth and for particular products; the planned additional US stock exchange listing; potential inorganic growth opportunities; e ...

Indivior PLC (INVVY) Q2 2022 Earnings Conference Call July 28, 2022 8:00 AM ET Company Participants Mark Crossley - Chief Executive Officer Ryan Preblick - Chief Financial Officer Christian Heidbreder - Chief Scientific Officer Conference Call Participants Max Herrmann - Stifel Peter Testa - One Investments Mark Crossley Good morning, good afternoon and thanks for joining us. With me today to discuss our Second Quarter and Half Year Results are Ryan Preblick, our Chief Financial Officer; and Dr. Christian H ...

Indivior PLC Q2 2022 Results July 28, 2022 AGENDA Overview & Strategic Priorities Update Mark Crossley Q2 / H1 Performance & FY 2022 Guidance Ryan Preblick R&D Update Christian Heidbreder Conclusion Mark Crossley Q&A All Mark Crossley Chief Executive Officer Forward-looking statements This presentation contains certain statements that are forward-looking. Forward-looking statements include, among other things, statements regarding the Indivior Group's financial guidance for 2022 and its medium- and long-ter ...

Indivior PLC Jefferies Healthcare Conference June 8, 2022 Forward-looking statements This presentation contains certain statements that are forward-looking. We cannot guarantee future results, events, levels of activity, performance or achievements. Actual results may differ materially from those expressed or implied in such statements because they relate to future events. You should not place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date that they are ma ...

Indivior PLC (INVVY) Q1 2022 Results Earnings Conference Call April 28, 2022 8:00 AM ET Company Participants Mark Crossley - Chief Executive Officer Ryan Preblick - Chief Financial Officer Christian Heidbreder - Chief Scientific Officer Conference Call Participants Paul Cuddon - Numis Securities Thibault Boutherin - Morgan Stanley Max Herrmann - Stifel Institutional James Vane-Tempest - Jefferies Peter Testa - One Investments Operator Good day. And thank you for standing by. Welcome to the Indivior PLC Q1 2 ...